Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Arkin, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Daar, ES; Lynn, H; Donfield, S; Gomperts, E; Hilgartner, MW; Hoots, WK; Chernoff, D; Arkin, S; Wong, WY; Winkler, CA
      Relation between HIV-1 and hepatitis C viral load in patients with hemophilia

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Dilixat, Y; Aytulun, S; Mayiram, S; Arkin, S; Ibadet, R; Sekine, M; Kagamimori, S
      Use of sand bathing for the treatment of arthritis and other conditions

      ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
    3. Arkin, S; Mahendra, N
      Discourse analysis of Alzheimer's patients before and after intervention: Methodology and outcomes

      APHASIOLOGY
    4. Daar, ES; Lynn, H; Donfield, S; Gomperts, E; O'Brien, SJ; Hilgartner, MW; Hoots, WK; Chernoff, D; Arkin, S; Wong, WY; Winkler, CA
      Hepatitis c virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs

      JOURNAL OF INFECTIOUS DISEASES
    5. Iancu, C; Mistry, SJ; Arkin, S; Wallenstein, S; Atweh, GF
      Effects of stathmin inhibition on the mitotic spindle

      JOURNAL OF CELL SCIENCE
    6. Silverman, LB; Gelber, RD; Dalton, VK; Asselin, BL; Barr, RD; Clavell, LA; Hurwitz, CA; Moghrabi, A; Samson, Y; Schorin, MA; Arkin, S; Declerck, L; Cohen, HJ; Sallan, SE
      Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01

      BLOOD
    7. Arkin, S; Blei, F; Fetten, J; Foulke, R; Gilchrist, GS; Heisel, MA; Key, N; Kisker, CT; Kitchen, C; Shafer, FE; Shah, PC; Strickland, D
      Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven (R) emergency-use programme in patients with severe haemophilia or with acquired inhibitors

      BLOOD COAGULATION & FIBRINOLYSIS
    8. Iancu, C; Mistry, SJ; Arkin, S; Atweh, GF
      Taxol and anti-stathmin therapy: A synergistic combination that targets the mitotic spindle

      CANCER RESEARCH
    9. Kisker, CT; Mahoney, EM; Arkin, S; Maeder, MA; Donfield, SM; Evatt, BL
      Changes in hepatitis B serologic titers in HIV+ and HIV- children with haemophilia

      HAEMOPHILIA
    10. Arkin, S; Cooper, HA; Hutter, JJ; Miller, S; Schmidt, ML; Seibel, NL; Shapiro, A; Warrier, I
      Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors - Results of the NovoSeven emergency-use program

      HAEMOSTASIS
    11. KAUFMAN FR; GERTNER JM; SLEEPER LA; DONFIELD SM; GOMPERTS E; KAUFMAN F; NELSON M; PEARSON S; HILGARTNER M; GERTNER J; GOLDBERG I; HOOTS WK; LOVELAND K; CANTINI M; WILLOUGHBY A; DONFIELD S; MAEDER MA; CONTANT C; KISKER CT; STEHBENS J; BALE J; COOL V; SIROIS P; SEXAUER C; HUSZTI H; HAWK S; ARKIN S; FORSTER A; SWINDELLS S; RICHARD S; PARMLEY R; MANGOS J; SCOTT A; HONECK L; LUSHER J; WARRIER I; BAIRDCOX K; HERSHEY MS; EYSTER ME; PATTISHALL E; NEAGLEY S; SHAPIRO A; HATCHER S; DAVIGNON G; RABWIN P; WICKLUND B; SPOOR M
      GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT

      Journal of acquired immune deficiency syndromes and human retrovirology
    12. LUSHER J; ARKIN S; ABILDGAARD CF; HURST A
      RECOMBINANT FVII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS

      Thrombosis and haemostasis
    13. MENDELSON J; ARKIN S; LIPTON JM
      INDEPENDENT EXPRESSION OF CD102 (ICAM-2) AND CD50 (ICAM-3), ON CD34 POSITIVE(+) HEMATOPOIETIC PROGENITORS

      Experimental hematology
    14. LUSHER J; ARKIN S; ABILDGAARD CF; HURST D
      KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS

      Blood
    15. JASON J; SLEEPER LA; DONFIELD SM; MURPHY J; WARRIER I; ARKIN S; EVATT B; WILLOUGHBY A; WASSERMAN J; PEQUEGNAT W; GOMPERTS E; KAUFMAN F; NELSON M; SCHULTZE ME; PEARSON S; HILGARTNER M; GERTNER J; SCIACCA J; HOOTS WK; LOVELAND K; CANTINI M; CURRY C; MCKINLAY S; DONFIELD S; MAEDER MA; CONTANT C; KISKER CT; STEHBENS J; BALE J; COOL V; ANDES WA; SIROIS P; SEXAUER C; OLSON R; BOWMAN M; HAWK S; ALEDORT L; ARROYO M; HAIRE W; ERICKSON J; PARMLEY R; MANGOS J; SCOTT A; HONECK L; LUSHER J; BAIRDCOX K; HERSHEY MS; EYSTER E; PATTISHALL E; SCHAFER J; NEAGLEY CS; SHAPIRO A; HATCHER S; DAVIGNON G; MOLLEN P; WICKLUND B; SPOOR M
      EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION

      Journal of acquired immune deficiency syndromes and human retrovirology
    16. LUSHER J; ARKIN S; ABILDGAARD CF; HURST D
      RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS

      Thrombosis and haemostasis
    17. ARKIN S; FERRONE S; LIPTON JM
      MODULATION OF ADHESION MOLECULE CD54 EXPRESSION ON CD34(+) HEMATOPOIETIC PROGENITORS

      Experimental hematology
    18. KRONER BL; GOEDERT JJ; BLATTNER WA; WILSON SE; CARRINGTON MN; MANN DL; OBRIEN SJ; WILLOUGHBY A; KESSEL W; DONFIELD SM; MCKINLAY SM; ALEDORT LM; ARKIN S; EYSTER ME; PATTISHALL EG; HILGARTNER MW; KONKLE B; WHITE GC; COHEN AR; BRAY GL; LUBAN N; KESSLER CM; RAGNI MV; LEDERMAN MM; LEISSINGER C; SIROIS P; MANCOJOHNSON M; DEMOERLOOSE P; MAHE A; HATZAKIS A; MANDALAKI T; SCHRAMM W; EICHINGER S; STINGL G; GOMPERTS ED; HOOTS WK; LOVELAND KA; KISKER CT; STEHBENS AA; CONTANT CF; HUSZTI H; SWINDELLS S; MANGOS J; WARRIER I; SHAPIRO AD; DAVIGNON GF; WICKLUND BM; WINKLER C
      CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS

      AIDS
    19. LUSHER JM; ARKIN S; ABILDGAARD CF; HURST D
      RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS

      Pediatric research
    20. MENDELSON J; ARKIN S; LIPTON JM
      CD102 (ICAM-2) AND CD50 (ICAM-3), UNLIKE CD54 (ICAM-1) ARE CONSTITUTIVELY EXPRESSED ON HEMATOPOIETIC PROGENITORS

      Blood
    21. PIZZOLATO J; GREENBERG D; STREETER G; MANFREDI J; LACKNER C; ARKIN S; TENDLER C
      P53 STATUS IN AIDS LYMPHOMA CELL-LINES CORRELATES WITH SENSITIVITY TOCHEMOTHERAPY AND RADIATION-INDUCED APOPTOSIS

      Blood
    22. ARKIN S; LUSHER J; ABILDGAARD C; BOGDANOFF D; HURST D
      PATTERN OF BLEEDING EPISODES IN YOUNG HEMOPHILIA-A PATIENTS - A NATURAL-HISTORY OF RECOMBINANT FACTOR-VIII (RFVIII) TREATMENT OF PREVIOUSLYUNTREATED PATIENTS (PUPS)

      Blood
    23. JASON J; MURPHY J; SLEEPER LA; DONFIELD SM; WARRIER I; ARKIN S; EVATT B; GOMPERTS ED
      DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS

      The FASEB journal
    24. JASON J; MURPHY J; SLEEPER LA; DONFIELD SM; WARRIER I; ARKIN S; EVATT B; GOMPERTS ED
      IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS

      American journal of hematology
    25. PRINZ J; ARKIN S
      ADLERIAN GROUP-THERAPY WITH SUBSTANCE-ABUSERS

      Individual psychology
    26. WARRIER I; LUSHER J; ARKIN S; ABILDGAARD C; TENGBORN L; HUTHKUEHNE A; HURST D
      CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE)

      Transfusion
    27. ARKIN S; BRODTMAN D; NAPRSTEK B; NEUMAN R; ALTER BP; LIPTON JM
      CELL-CYCLE ANALYSIS IN FANCONI-ANEMIA - A DIAGNOSTIC-TEST

      Pediatric research
    28. LUSHER J; ARKIN S; ABILDGAARD C; INWOOD M; HILGARTNER M; HURST D
      INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE

      Pediatric research
    29. LUSHER J; ARKIN S; ABILDGAARD CF; HURST D
      KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS

      Blood
    30. BRAY GL; GOMPERTS ED; COURTER S; GRUPPO R; GORDON EM; MANCOJOHNSON M; SHAPIRO A; SCHEIBEL E; WHITE G; LEE M; GORDON M; BERTALONE S; LIPTON R; HILGARTNER M; ARKIN S; GILL J; KIM H; SHURIN S; SANTIAGOBORRERO P; ARKEL YS; KULKARNI R; GREENWOOD MF; RITCHEY AK; WERNER E; HAIRE WD; KISKER T; NEUFELD E; EWENSTEIN B; DEBIASI R; LAURIAN Y; KREUZ W; RODEGHIERO F; INGERSLEV J; GAZENGEL C; DIMICHELE D; COOPER H
      A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A

      Blood
    31. MANNUCCI PM; BRETTLER DB; ALEDORT LM; LUSHER JM; ABILDGAARD CF; SCHWARTZ RS; HURST D; JOLLY K; HARRISON J; ADDIEGO JE; JEREB R; ARKIN S; ALEDORT LM; FOSTER A; SEREMETIS S; DASANI H; HARRISON J; HILGARTNER MW; BOARDS N; INWOOD MJ; CLEGG E; KASPER C; MOCKARY P; KRILL C; DERY A; MILLER E; LEVINE P; FORSBERG A; VALDEZ L; JACQUES S; PFAFFMAN L; WARRIOR I; BRACKMANN HH; GRINGERI A; SANTAGOSTINO E; SCHARRER I; LEE C; ALLRED RU; BOGDANOFF D; DONALDSON D; MACKENZIE MA; BAILEY P; DYLA S; PENNINGTON JE; ZACCARINI P; LEIGH P; NEUMANN R; FUKUI H
      IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII

      Blood
    32. MILLER TT; CALDWELL G; KAYE JJ; ARKIN S; BURKE S; BRILL PW
      MR-IMAGING OF DEFEROXAMINE-INDUCED BONE DYSPLASIA IN AN 8-YEAR-OLD FEMALE WITH THALASSEMIA MAJOR

      Pediatric radiology
    33. LUSHER JM; ARKIN S; ABILDGAARD CF; INWOOD M; ZIMMERMANN R; HILGARTNER M; HURST D
      INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE

      Blood
    34. ARKIN S; BRODTMAN D; ALTER BP; LIPTON JM
      A SCREENING-TEST FOR FANCONI-ANEMIA USING FLOW-CYTOMETRY

      Blood
    35. WARRIER I; ARKIN S; ABILDGAARD C; TENGBOM L; ZIMMERMANN R; HURST D
      CD-4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS (PUPS) WITHHEMOPHILIA-A RECEIVING RECOMBINANT FVIII (KOGENATE)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:40:28